Stock Snapshot
Price Performance
Recommendation Rationale
Favorable growth outlook supported by network expansion and strategic investments.
Basis of our Recommendation
Vijaya Diagnostic is poised for strong growth, targeting a 15% revenue CAGR over the next few years, driven by network expansion and strategic investments in new hubs. The company is capitalizing on favorable market trends, including rising health awareness and increased demand for diagnostics. However, execution risks and competitive pressures from AI-driven players present challenges that need to be managed.
Why We Like This Stock
- Targeting 15% revenue CAGR driven by organic growth and network expansion
- Significant capex plan for new hub additions to enhance market presence
- Rising wellness awareness and insurance-driven formalization of diagnostics
Things To Watch Out For
- Execution risks due to recent leadership changes
- Competitive threats from AI-first diagnostic players
Key Parameters
Financial Snapshot
| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 548 | 681 | 814 | 944 | 1,088 |
| Profit Before Tax (Cr.) | 143 | 186 | 233 | 273 | 317 |
| PBT Margin | 26.1% | 27.3% | 28.6% | 29.0% | 29.2% |
| Net Profit (Cr.) | 114 | 147 | 182 | 213 | 247 |
| EPS | 11.0 | 14.2 | 17.7 | 20.7 | 24.0 |
Company Overview
Show Company Profile
Vijaya Diagnostic Centre Limited provides diagnostic services for patients in India. The company offers laboratory services, including clinical pathology, microbiology, haematology, serology, histopathology, cytogenetics, biochemistry, molecular diagnostics, CT scan, magnetic resonance imaging (MRI) scan, ultrasound, X-ray, cardiology, gastroenterology, nuclear medicine and PET/CT, and MRI-3T services. It also provides health checkups and home sample collection services. Vijaya Diagnostic Centre Limited was founded in 1981 and is based in Hyderabad, India.